[PCRX] YoY Quarter Result on 31-Dec-2022 [#Q4]

Stock
[PCRX] Pacira BioSciences, Inc.
Announcement Date
28-Feb-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- -1,357.72%
YoY- -96.96%
Quarter Report
PCRX's Result
PCRX's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 181,244 171,955 159,194 128,548 122,424 95,115 79,078 14.81%
PBT 33,720 -18,068 -6,197 12,693 -3,541 8,322 4,630 39.20%
Tax 8,850 -7,966 -1,068 -1,821 1,347 37 35 151.36%
NP 24,870 -10,102 -5,129 14,514 -4,888 8,285 4,595 32.48%
Tax Rate -26.25% - - 14.35% - -0.44% -0.76% -
Total Cost 156,374 182,057 164,323 114,034 127,312 86,830 74,483 13.15%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin 13.72 -5.87 -3.22 11.29 -3.99 8.71 5.81 15.38%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS 0.54 -0.22 -0.12 0.33 -0.12 0.20 0.11 30.35%
EPS Diluted 0.48 -0.22 -0.12 0.32 -0.12 0.20 0.11 27.81%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.